← Leaderboards
Martin W Lock
Regenx Biosciences, Llc
$1,093,568
Attributed
$1,225,206
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $471.7K · FY2010–13$500K$375K$250K$125K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$1,225,206 · 2
By mechanism
P01$961,929 · 1
R43$263,277 · 1
Top collaborators
- Karen Kozarsky1 shared
Most similar at Regenx Biosciences, Llc
Same institution · by research overlap
- Karen Kozarsky$1,931,365
Others in their field
Top investigators on “Familial Hypercholesterolemia”
- Jane S Paulsen · University Of Wisconsin-Madison$10,594,370
- Michael D Geschwind · University Of California San Francisco$10,594,370
- Donna K. Arnett · University Of Minnesota Twin Cities$9,476,068
- Macrae F Linton · Vanderbilt University Medical Center$6,837,142
- Daniel James Rader · University Of Pennsylvania$6,530,593
- Sean Stephen Davies · Vanderbilt University Medical Center$6,501,580
Research focus
Familial HypercholesterolemiaAdenovirusesSerotypingTechnologyLaboratoriesGene TherapyLarge Scale ProductionProductionVectorGenerationsDependovirusBaseAdenovirus VectorGood Laboratory PracticeCardiovascular DiseasesAreaGuidelinesInterestArchivesEquipmentControl GroupsDocumentationBasic ScienceGene Delivery
Grant awards (5)
VECTOR CORE$255,312
P01 · FY2013 · HL · contact PI
VECTOR CORE$256,707
P01 · FY2012 · HL · contact PI
VECTOR CORE$241,448
P01 · FY2011 · HL · contact PI
Scalable Production of New Generation Adeno-Associated Virus Gene Therapy Vectors$263,277
R43 · FY2010 · DK
VECTOR CORE$208,462
P01 · FY2010 · HL · contact PI